Phreesia, Inc. (NYSE:PHR – Get Free Report) insider Yvonne Hui sold 744 shares of the firm’s stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $23.25, for a total value of $17,298.00. Following the transaction, the insider now directly owns 30,019 shares in the company, valued at approximately $697,941.75. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.
Yvonne Hui also recently made the following trade(s):
- On Tuesday, July 16th, Yvonne Hui sold 283 shares of Phreesia stock. The shares were sold at an average price of $23.74, for a total value of $6,718.42.
Phreesia Price Performance
Shares of PHR opened at $24.69 on Friday. The firm has a market capitalization of $1.42 billion, a PE ratio of -11.38 and a beta of 0.93. The stock’s 50 day moving average is $23.72 and its two-hundred day moving average is $22.73. Phreesia, Inc. has a twelve month low of $12.05 and a twelve month high of $29.16. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.03.
Institutional Trading of Phreesia
Analysts Set New Price Targets
Several research firms have commented on PHR. Canaccord Genuity Group reaffirmed a “buy” rating and set a $34.00 price target on shares of Phreesia in a research report on Thursday, September 5th. Stephens reiterated an “overweight” rating and issued a $28.00 price target on shares of Phreesia in a research report on Friday, May 31st. JMP Securities reissued a “market outperform” rating and set a $30.00 price objective on shares of Phreesia in a research report on Thursday, September 5th. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $23.00 target price on shares of Phreesia in a report on Thursday, September 5th. Finally, JPMorgan Chase & Co. raised their price target on Phreesia from $27.00 to $28.00 and gave the stock an “overweight” rating in a report on Monday, September 9th. One analyst has rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $29.42.
View Our Latest Stock Report on Phreesia
Phreesia Company Profile
Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.
See Also
- Five stocks we like better than Phreesia
- What is Forex and How Does it Work?
- Symbotic’s Double-Bagger Potential as It Hits a Key Inflection
- Overbought Stocks Explained: Should You Trade Them?
- High Dividend Yields Make These 2 Shipping Stocks Stand Out
- 10 Best Airline Stocks to Buy
- Can Celsius Stock Rebound? Analysts See 74% Upside Potential
Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.